Labcorp
742 hedge funds and large institutions have $11B invested in Labcorp in 2018 Q4 according to their latest regulatory filings, with 84 funds opening new positions, 243 increasing their positions, 313 reducing their positions, and 130 closing their positions.
51% more call options, than puts
Call options by funds: $24.1M | Put options by funds: $15.9M
3.23% less ownership
Funds ownership: 106.71% → 103.48% (-3.2%)
6% less funds holding
Funds holding: 793 → 742 (-51)
20% less funds holding in top 10
Funds holding in top 10: 15 → 12 (-3)
22% less repeat investments, than reductions
Existing positions increased: 243 | Existing positions reduced: 313
32% less capital invested
Capital invested by funds: $16.2B → $11B (-$5.18B)
35% less first-time investments, than exits
New positions opened: 84 | Existing positions closed: 130
Top Buyers
| 1 |
Lazard Asset Management
New York
|
+$124M |
| 2 |
BlackRock
New York
|
+$98.7M |
| 3 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$45.8M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$45.4M |
| 5 |
State of New Jersey Common Pension Fund D
Trenton,
New Jersey
|
+$34.3M |
Top Sellers
| 1 |
Boston Partners
Boston,
Massachusetts
|
-$186M |
| 2 |
O
OppenheimerFunds
New York
|
-$118M |
| 3 |
HM
HealthCor Management
New York
|
-$106M |
| 4 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
-$91.5M |
| 5 |
Jennison Associates
New York
|
-$66.2M |
LH Hedge Fund Activity: Q4 2018 in Review
742 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Labcorp (LH) for Q4 2018, worth a combined $11B — down 32% from $16.2B a quarter earlier.
Sellers outnumbered buyers: 130 funds closed out of LH and 84 opened new positions — a net loss of 46 holders — while 313 trimmed existing stakes and 243 added.
The largest buyer was Lazard Asset Management, adding an estimated $124M. The largest seller was Boston Partners, cutting an estimated $186M.
- 742 institutional investors held Labcorp (LH) as of Q4 2018, down from 793 in Q3 2018.
- Funds reported $11B of Labcorp stock for Q4 2018, down 32% quarter-over-quarter.
- 84 funds opened new Labcorp positions in Q4 2018 and 130 closed out, a net change of -46 holders.
- The largest Labcorp buyer in Q4 2018 was Lazard Asset Management, an estimated $124M added.
- The largest Labcorp seller in Q4 2018 was Boston Partners, an estimated $186M sold.
Based on aggregated 13F filings for Q4 2018.